A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

Clinical trial NCT05444257 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05444257
Sponsor: Vertex Pharmaceuticals Incorporated
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2022-11-08
Primary completion: 2026-10-30
Enrollment: 822

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.